Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

IDXG

Interpace Biosciences, Inc.

Interpace Biosciences, Inc.: Combining Molecular Diagnostics, Bioinformatics, and Pathology Services to Revolutionize Cancer Risk Evaluation in the United States Interpace Biosciences, Inc. has be...

Interpace Biosciences, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

FAB

Fusion Antibodies Plc

Fusion Antibodies Plc is a company focused on discovering antibodies that can help revolutionize the healthcare industry. The company provides a comprehensive range of services related to antibodie...

Fusion Antibodies Plc Annual Report 2023

Healthcare Biotechnology LSE 11-50

CEMI

Chembio Diagnostics

Chembio Diagnostics, a leading biotechnology company, has made headlines with its impressive portfolio of point-of-care (POC) diagnostic tests used to diagnose various diseases. The company offers ...

Chembio Diagnostics Annual Report 2021

Healthcare Diagnostic Substances NASDAQ 51-200

AIMT

Aimmune Therapeutics, Inc.

Aimmune Therapeutics is a biopharmaceutical company focused on developing cures for food allergies. The company's Characterized Oral Desensitization (CODIT) approach is designed to protect patients...

Aimmune Therapeutics, Inc. Annual Report 2018

Healthcare Biotechnology NASDAQ 501-1000

RENX

Renalytix AI plc

Renalytix is a pioneering company in the emerging field of bioprognosis for kidney health. Its innovative solution allows for early-stage risk assessment, helping patients manage their condition be...

Renalytix AI plc Annual Report 2023

Healthcare LSE 1-10

ATHX

Athersys

Cleveland-based biotechnology firm Athersys, Inc. is at the forefront of pioneering research and development activities in the field of regenerative medicine. The company's clinical development pro...

Athersys Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

YMAB

Y-mAbs Therapeutics Inc

Y-mAbs Therapeutics, Inc. is a biopharmaceutical company that is focused on the development and commercialization of unique antibody-based therapeutic products for the treatment of cancer in the Un...

Y-mAbs Therapeutics Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

MRSN

Mersana Therapeutics

Mersana Therapeutics, a Cambridge-based clinical stage biopharmaceutical firm, is making strides in developing antibody drug conjugates (ADC) to treat cancer patients with unmet needs. The company'...

Mersana Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

GRTS

Gritstone bio

Gritstone bio, Inc. is a biotechnology company that is presently engaged in the development of innovative vaccine-based immunotherapy candidates for the treatment of cancer and infectious diseases ...

Gritstone bio Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SNDA

Sonida Senior Living

Addison, Texas-based Sonida Senior Living, Inc. operates a number of senior housing communities across the United States, providing comprehensive services to residents. The company's independent li...

Sonida Senior Living Annual Report 2019

Healthcare Long-Term Care Facilities NYSE 1001-5000

HXL

Hexcel

Stamford-based Hexcel Corporation has established itself as a reliable manufacturer and marketer of a variety of advanced materials and products for a range of sectors, including commercial aviatio...

Hexcel Annual Report 2021

Healthcare Biotechnology ASX 11-50

BNTC

Benitec Biopharma Inc.

Hayward-based Benitec Biopharma Inc., a promising biotechnology firm at the developmental stage, has made genetic medicines its top priority. With a focus on DNA-directed RNA interference-based the...

Benitec Biopharma Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

ODX

Omega Diagnostics Group PLC

Omega Diagnostics Group PLC, a UK-based company, is committed to advancing human health and well-being through cutting-edge diagnostic tests and global collaborations. The company specializes in pr...

Omega Diagnostics Group PLC Annual Report 2023

Healthcare Medical Instruments & Supplies LSE 51-200

DXRX.L

Diaceutics PLC

UK-based Diaceutics PLC is making waves in the world of precision medicine diagnostics. Its DXRX platform offers various solutions to pharmaceutical, diagnostic and laboratory companies looking for...

Diaceutics PLC Annual Report 2023

Healthcare Biotechnology LSE 51-200

LPCN

Lipocine Inc.

Lipocine Inc., a biopharmaceutical company in the midst of clinical development, is dedicated to the pursuit of drug delivery solutions for central nervous system (CNS) disorders. The company has a...

Lipocine Inc. Annual Report 2023

Healthcare Drugs - Generic NASDAQ 11-50